415 related articles for article (PubMed ID: 22085385)
1. Pharmacological considerations for the proper clinical use of aminoglycosides.
Pagkalis S; Mantadakis E; Mavros MN; Ammari C; Falagas ME
Drugs; 2011 Dec; 71(17):2277-94. PubMed ID: 22085385
[TBL] [Abstract][Full Text] [Related]
2. Extended-interval aminoglycoside administration for children: a meta-analysis.
Contopoulos-Ioannidis DG; Giotis ND; Baliatsa DV; Ioannidis JP
Pediatrics; 2004 Jul; 114(1):e111-8. PubMed ID: 15231982
[TBL] [Abstract][Full Text] [Related]
3. Reappraisal of Contemporary Pharmacokinetic and Pharmacodynamic Principles for Informing Aminoglycoside Dosing.
Bland CM; Pai MP; Lodise TP
Pharmacotherapy; 2018 Dec; 38(12):1229-1238. PubMed ID: 30403305
[TBL] [Abstract][Full Text] [Related]
4. The use of extended-interval aminoglycoside dosing strategies for the treatment of moderate-to-severe infections encountered in critically ill surgical patients.
Mueller EW; Boucher BA
Surg Infect (Larchmt); 2009 Dec; 10(6):563-70. PubMed ID: 20035611
[TBL] [Abstract][Full Text] [Related]
5. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
[TBL] [Abstract][Full Text] [Related]
6. Efficacy, nephrotoxicity and ototoxicity of aminoglycosides, mathematically modelled for modelling-supported therapeutic drug monitoring.
Croes S; Koop AH; van Gils SA; Neef C
Eur J Pharm Sci; 2012 Jan; 45(1-2):90-100. PubMed ID: 22094306
[TBL] [Abstract][Full Text] [Related]
7. Once-daily versus multiple-daily dosing of aminoglycosides.
Craig WA
J Chemother; 1995 Jun; 7 Suppl 2():47-52. PubMed ID: 8622110
[TBL] [Abstract][Full Text] [Related]
8. Optimizing use of aminoglycosides in the critically ill.
Rea RS; Capitano B
Semin Respir Crit Care Med; 2007 Dec; 28(6):596-603. PubMed ID: 18095223
[TBL] [Abstract][Full Text] [Related]
9. Adaptation in neonatology of the once-daily concept of aminoglycoside administration: evaluation of a dosing chart for amikacin in an intensive care unit.
Langhendries JP; Battisti O; Bertrand JM; François A; Kalenga M; Darimont J; Scalais E; Wallemacq P
Biol Neonate; 1998 Nov; 74(5):351-62. PubMed ID: 9742264
[TBL] [Abstract][Full Text] [Related]
10. Aminoglycosides in septic shock: an overview, with specific consideration given to their nephrotoxic risk.
Boyer A; Gruson D; Bouchet S; Clouzeau B; Hoang-Nam B; Vargas F; Gilles H; Molimard M; Rogues AM; Moore N
Drug Saf; 2013 Apr; 36(4):217-30. PubMed ID: 23508544
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamic modeling of aminoglycosides against Pseudomonas aeruginosa and Acinetobacter baumannii: identifying dosing regimens to suppress resistance development.
Tam VH; Ledesma KR; Vo G; Kabbara S; Lim TP; Nikolaou M
Antimicrob Agents Chemother; 2008 Nov; 52(11):3987-93. PubMed ID: 18725438
[TBL] [Abstract][Full Text] [Related]
12. Aminoglycosides: a practical review.
Gonzalez LS; Spencer JP
Am Fam Physician; 1998 Nov; 58(8):1811-20. PubMed ID: 9835856
[TBL] [Abstract][Full Text] [Related]
13. Once-daily dosing of aminoglycosides: review and recommendations for clinical practice.
Freeman CD; Nicolau DP; Belliveau PP; Nightingale CH
J Antimicrob Chemother; 1997 Jun; 39(6):677-86. PubMed ID: 9222035
[TBL] [Abstract][Full Text] [Related]
14. Management of aminoglycosides in the intensive care unit.
Radigan EA; Gilchrist NA; Miller MA
J Intensive Care Med; 2010; 25(6):327-42. PubMed ID: 20837630
[TBL] [Abstract][Full Text] [Related]
15. Can Pharmacokinetic and Pharmacodynamic Principles Be Applied to the Treatment of Multidrug-Resistant Acinetobacter?
Cooper TW; Pass SE; Brouse SD; Hall RG
Ann Pharmacother; 2011 Feb; 45(2):229-40. PubMed ID: 21304038
[TBL] [Abstract][Full Text] [Related]
16. Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity.
Rybak MJ; Abate BJ; Kang SL; Ruffing MJ; Lerner SA; Drusano GL
Antimicrob Agents Chemother; 1999 Jul; 43(7):1549-55. PubMed ID: 10390201
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic monitoring of amikacin and gentamicin in routine clinical practice].
Kacířová I; Grundmann M
Vnitr Lek; 2015 Jan; 61(1):33-41. PubMed ID: 25693614
[TBL] [Abstract][Full Text] [Related]
18. Extended-interval once-daily dosing of aminoglycosides in adult and pediatric patients with cystic fibrosis.
Prescott WA; Nagel JL
Pharmacotherapy; 2010 Jan; 30(1):95-108. PubMed ID: 20030477
[TBL] [Abstract][Full Text] [Related]
19. Aminoglycoside therapy in infectious diseases.
Poulikakos P; Falagas ME
Expert Opin Pharmacother; 2013 Aug; 14(12):1585-97. PubMed ID: 23746121
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis.
Roberts JA; Lipman J
Clin Pharmacokinet; 2006; 45(8):755-73. PubMed ID: 16884316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
